| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/25/2009 | US20090162285 Anti-inflammatory fusion protein |
| 06/25/2009 | DE3943838B4 Kompositionen zur topischen Anwendung enthaltend Cyclosporine Compositions for topical application containing Cyclosporine |
| 06/25/2009 | DE202005021713U1 Rekombinante Spinnenseidenproteine Recombinant spider silk proteins |
| 06/25/2009 | DE102008062373A1 Mittel, mit mindestens einem Wirkstoff, der eine Zahnfleischwachstumswirkung aufweist Means, with at least one active ingredient that comprises a gum growth effect |
| 06/25/2009 | CA2710061A1 Rhoc-based immunotherapy |
| 06/25/2009 | CA2709579A1 Materials and methods for treatment of pathological ocular vascular proliferation |
| 06/25/2009 | CA2709566A1 Stem-like cells and method for reprogramming adult mammalian somatic cells |
| 06/25/2009 | CA2709555A1 Treatment of inflammatory illnesses with ace2 |
| 06/25/2009 | CA2709463A1 Trail variants for treating cancer |
| 06/25/2009 | CA2709159A1 Compositions and methods for increasing iron absorption |
| 06/25/2009 | CA2708956A1 Compounds and methods for the treatment of vascular disease |
| 06/25/2009 | CA2708658A1 Treatment and prevention of hiv infection |
| 06/25/2009 | CA2708168A1 Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa) |
| 06/25/2009 | CA2708080A1 Antitumoral compounds |
| 06/25/2009 | CA2707309A1 Novel addl receptor polypeptides, polynucleotides and host cells for recombinant production |
| 06/25/2009 | CA2707051A1 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 06/24/2009 | EP2072619A1 Factor involved in metastasis and uses thereof |
| 06/24/2009 | EP2072525A1 New polypeptides having affinity for HER2 |
| 06/24/2009 | EP2072524A2 Anti-inflammatory peptides |
| 06/24/2009 | EP2072057A1 Early administration of Botulinum toxin in the treatment of cerebrovascular event and spinal cord injury |
| 06/24/2009 | EP2072056A1 Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 06/24/2009 | EP2072040A1 Therapeutic use of nucleic acid micropheres |
| 06/24/2009 | EP2072039A1 Use of a neurotoxic component of Clostridium botulinum toxin complex to reduce or prevent side effects |
| 06/24/2009 | EP1951890A4 Methods and compositions comprising non-natural amino acids |
| 06/24/2009 | EP1801119B1 Interleukin-15 antagonist peptide |
| 06/24/2009 | EP1737881B1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/24/2009 | EP1725224A4 Methods and compositions comprising non-peptide small molecules that solubilize beta amyloid peptide fiber |
| 06/24/2009 | EP1651246A4 Method for promoting bone growth |
| 06/24/2009 | EP1641485A4 Inhibition of sars coronavirus infection with clinically approved antiviral drugs |
| 06/24/2009 | EP1617855A4 Antimicrobial peptide and methods of use thereof |
| 06/24/2009 | EP1579865A4 Means for preventing and curing endocrine system disturbances |
| 06/24/2009 | EP1572291A4 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 06/24/2009 | EP1565200A4 Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer |
| 06/24/2009 | EP1553968A4 Method for treating patients with massive blood loss |
| 06/24/2009 | EP1546090B1 Method for producing acylated peptides |
| 06/24/2009 | EP1509243A4 Topical drug delivery using phosphatidylcholine |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1482966A4 Method and composition for treating skin wounds with epidermal growth factor |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1429650B1 Alternatively spliced circulating tissue factor |
| 06/24/2009 | EP1324767B1 Plasminogen activator to prevent corneal and subepithelial haze after laser vision correction surgery |
| 06/24/2009 | EP1314436B1 Antiviral composition comprising interferon in the form of nose drops |
| 06/24/2009 | EP1303591B1 Masp-2, a complement-fixing enzyme, and uses for it |
| 06/24/2009 | EP1131106B1 Compositions and methods for producing vascular occlusion |
| 06/24/2009 | EP1011733B1 Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 06/24/2009 | CN101466401A Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 06/24/2009 | CN101466400A Covalent factor VII-tissue factor complex |
| 06/24/2009 | CN101466399A Stabilized insulin-like growth factor polypeptides |
| 06/24/2009 | CN101466398A Stabilized insulin-like growth factor polypeptides |
| 06/24/2009 | CN101466397A Method for treating disease or disorder of adult central nervous system associated with tissue shrinkage or atrophy by administration of insulin |
| 06/24/2009 | CN101466396A Dosing regimes for LH or HCG and EPO for treatment of neurological disorders |
| 06/24/2009 | CN101466395A Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma |
| 06/24/2009 | CN101466394A Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof |
| 06/24/2009 | CN101466393A Method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia |
| 06/24/2009 | CN101466391A Inhibition of tumor growth |
| 06/24/2009 | CN101466390A Pharmaceutical composition with synergistic anticonvulsant effect |
| 06/24/2009 | CN101466389A Formulation comprising whey protein and hydrolysates for improving muscle recovery |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN101461939A Angiotensin converting enzyme inhibitor and preparation thereof |
| 06/24/2009 | CN101461938A Preparation for treating flat wart and preparation method thereof |
| 06/24/2009 | CN101461937A Pig interferon inducer and use |
| 06/24/2009 | CN101461936A Composition with function for promoting lead-expelling and method for preparing the same |
| 06/24/2009 | CN101461935A Composition with function for promoting lead-expelling and method for preparing the same |
| 06/24/2009 | CN101461934A Application of small-molecule peptide in preparing medicament and food for promoting wound healing after operation |
| 06/24/2009 | CN100503829C Interleukin-18 mutants, their production and use |
| 06/24/2009 | CN100503639C Recombinant tumor specific antibody and use thereof |
| 06/24/2009 | CN100503637C Glucagon-like peptide analog, its composition and its using method |
| 06/24/2009 | CN100503635C Crystal of human avidin protein and preparation thereof |
| 06/24/2009 | CN100502944C Asparaginase injection its preparing method and use |
| 06/24/2009 | CN100502943C Drug injection of recombinant human erythropoietin |
| 06/24/2009 | CN100502942C Application of liver cell growth factor in preventing and treating tissue adhesion |
| 06/24/2009 | CN100502941C Hirudin dry powder inhalant and preparing method |
| 06/24/2009 | CN100502940C Healing agent for intestinal mucosal injury and its preparation method |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | USRE40789 Mammalian checkpoint proteins polypeptides and encoding sequences thereof |
| 06/23/2009 | USRE40786 IMMUNOSTIMULAnts COMPOSITION COMPRISING IMMUNOGENIC SUBSTANCE ENCAPSULATED IN POLYLACTIDE-CO-GLYCOLIDE MATRIX; vaccine for HIV-1 |
| 06/23/2009 | US7550598 Kinase inhibitors |
| 06/23/2009 | US7550582 labeled Peptide Nucleic Acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone for fluorescence in-situ hybridization (FISH) detection; can be purified using chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents |
| 06/23/2009 | US7550573 Nucleotide sequences coding polypeptides for use in the treatment of thrombosis, arthritis and cell proliferation defects |
| 06/23/2009 | US7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 06/23/2009 | US7550567 Contaminating proteins are depleted by negative chromatography and/or negative adsorption using cation exchanger, hydrophobic gel and/or dye gel; improved stability; fibrin glue |
| 06/23/2009 | US7550566 G-CSF conjugates |
| 06/23/2009 | US7550565 G-CSF conjugates |
| 06/23/2009 | US7550563 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (Ig-like) domain |
| 06/23/2009 | US7550562 Having pathogenic activity that can induce pemphigus lesion; a peptide specifically recognized by the monoclonal antibody and useful as a therapeutic drug for pemphigus autoimmune disease; drug screening |
| 06/23/2009 | US7550560 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 06/23/2009 | US7550558 Antimicrobial peptides and methods for identifying and using such peptides |
| 06/23/2009 | US7550439 Methods for reducing oxidative damage |
| 06/23/2009 | US7550438 culture product protein obtained from culturing kidney epithelial cells of BSC-1 African green monkey kidney epithelial cell line; for perfusing ex vivo a donor human kidney, intended for transplantation into a new host; treating and diagnosing patients with kidney disease |
| 06/23/2009 | US7550437 administering a protein agonist for protease-activated receptor (PAR-2); side effects reduction; peptidase inhibitors (amistatins); drug delivery; biodrugs as antisecretory agents |
| 06/23/2009 | US7550436 Compositions containing peptide and electrolyte excretion promoter and foods containing the same |
| 06/23/2009 | US7550435 Administering isolated omentin polypeptides that selectively express in omental fat tissue, promoting glucose uptake by animal adipocytes |
| 06/23/2009 | US7550434 preparing a sealed vial or sealed cartridge for storage stability, resist to oxidation and chemical; including BUFFER AND A POLYOL; MANNITOL, BUFFER OF AN ACETATE OR TARTRATE, M-CRESOL OR BENZYL ALCOHOL PRESERVATIVE; parathyroid hormone for treating osteoporosis |
| 06/23/2009 | US7550433 Erythropoietin receptor peptide formulations and uses |
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550431 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 06/23/2009 | US7550430 Bactericides; immobilized |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550428 treating fungal infections; improved thermal stability and water solubility; releasing carbohydrate upon dispersion of the complex in water |
| 06/23/2009 | US7550427 Poly-pegylated protease inhibitors |